.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
McKesson
Medtronic
Healthtrust
Express Scripts
Harvard Business School
McKinsey
Merck
Deloitte
Novartis

Generated: July 21, 2017

DrugPatentWatch Database Preview

Actavis Labs Fl Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS FL INC, and what generic and branded alternatives to ACTAVIS LABS FL INC drugs are available?

ACTAVIS LABS FL INC has sixty-nine approved drugs.

There is are four approvals on ACTAVIS LABS FL INC drugs.

Summary for Applicant: Actavis Labs Fl Inc

Patents:0
Tradenames:54
Ingredients:52
NDAs:69
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc
POTASSIUM CHLORIDE
potassium chloride
CAPSULE, EXTENDED RELEASE;ORAL077419-002Jun 2, 2008ABRXNoYes► Subscribe► Subscribe
Actavis Labs Fl Inc
ALPRAZOLAM
alprazolam
TABLET, EXTENDED RELEASE;ORAL077198-003May 13, 2010DISCNNoNo► Subscribe► Subscribe
Actavis Labs Fl Inc
TAZTIA XT
diltiazem hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL075401-002Apr 10, 2003AB4RXNoNo► Subscribe► Subscribe
Actavis Labs Fl Inc
KETOPROFEN
ketoprofen
CAPSULE, EXTENDED RELEASE;ORAL075270-001Mar 24, 1999ABRXNoNo► Subscribe► Subscribe
Actavis Labs Fl Inc
LACOSAMIDE
lacosamide
TABLET;ORAL204855-001Apr 28, 2016ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Cantor Fitzgerald
Deloitte
Harvard Business School
US Army
Queensland Health
Novartis
AstraZeneca
Daiichi Sankyo
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot